Lethal Injection Failures Are Features, Not Glitches, Says Death Row Consultant

The failures keep happening. A line goes bad. The drugs don't flow right. The condemned person takes longer to die than the protocol says they should. Each time, officials call it a glitch—a technical problem, a one-off, something that can be fixed with better training or sharper needles or more attentive staff. But someone who has spent years inside the machinery of capital punishment argues this framing misses something fundamental: the failures are not accidents. They are built into the system itself.

This assessment comes from someone with direct experience advising legal teams representing people on death row. The consultant has watched how executions actually unfold, not how they are supposed to unfold on paper. What emerges from that vantage point is a picture of lethal injection as a process riddled with structural problems that no amount of procedural tinkering can resolve. The drugs themselves are unreliable. The people administering them often lack medical training. The protocols shift from state to state, creating a patchwork of standards with no real oversight. When something goes wrong—and something often does—the system treats it as an anomaly rather than evidence of a deeper design failure.

The case of Christa Pike illustrates the point. Pike was executed by lethal injection, and the execution itself became a window into how these procedures actually work when the cameras are off and the stakes are absolute. The process failed in ways that revealed not a single mistake but a cascade of systemic vulnerabilities. The execution took longer than anticipated. The drugs did not behave as expected. What was supposed to be a controlled, clinical procedure became something messier and more troubling.

When executions go wrong, the standard response is to blame the technician—the person who could not find a vein, or who did not monitor the IV properly, or who did not follow the checklist. But this consultant's work suggests the problem runs deeper. Lethal injection as a method carries inherent uncertainties that no amount of individual competence can eliminate. The drugs are not pharmaceutical-grade in many cases. The dosages are based on limited scientific evidence. The entire apparatus depends on assumptions about how bodies respond that have never been rigorously tested. States adopted lethal injection partly because it seemed more humane than other methods, but also because it seemed more clinical, more controllable. The reality has proven otherwise.

The argument being made here is not that executions should be abandoned because they sometimes fail. It is that the failures themselves are telling us something important about the method. They are not glitches to be debugged. They are features—inevitable consequences of trying to use a pharmaceutical process designed for healing to accomplish something else entirely. The system was never designed to work reliably in the way that matters. It was designed to appear to work reliably, which is a different thing altogether.

This distinction matters because it changes what we should be asking. If failures are glitches, the question becomes: How do we fix them? But if failures are features, the question becomes: What does this tell us about the entire enterprise? The consultant's position suggests that capital punishment methods require not technical refinement but fundamental reconsideration. The problem is not that we are doing lethal injection badly. The problem is that lethal injection, as currently practiced, cannot be done in a way that eliminates the recurring failures we keep witnessing. Until that reality is acknowledged, each execution will carry the same structural vulnerabilities that made the previous ones go wrong.